A5073625177- Reproductive Health and Contraception
- Global Maternal and Child Health
- Maternal and Perinatal Health Interventions
- Reproductive Health and Technologies
- Adolescent Sexual and Reproductive Health
- Maternal and fetal healthcare
- Gynecological conditions and treatments
- Pregnancy and Medication Impact
- Sexual function and dysfunction studies
- HIV/AIDS Research and Interventions
- Uterine Myomas and Treatments
- Ectopic Pregnancy Diagnosis and Management
- Reproductive tract infections research
- Assisted Reproductive Technology and Twin Pregnancy
- Poverty, Education, and Child Welfare
- Maternal Mental Health During Pregnancy and Postpartum
- Endometriosis Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Reproductive System and Pregnancy
- Demographic Trends and Gender Preferences
- Ovarian function and disorders
- Ureteral procedures and complications
- Gender, Labor, and Family Dynamics
- Healthcare Systems and Reforms
- Menstrual Health and Disorders
Family Health International 360
2014-2024
University of California, San Francisco
2024
Oregon Health & Science University
2024
RELX Group (United States)
2012-2018
Durham University
2013-2015
RELX Group (United Kingdom)
2012-2015
Research Triangle Park Foundation
2004-2014
Triangle
2002-2013
University of North Carolina at Chapel Hill
2013
Karolinska University Hospital
2013
Previous studies of intrauterine devices (IUDs), many which are no longer in use, suggested that they might cause tubal infertility. The concern IUDs contain copper — currently the most commonly used type may increase risk infertility nulligravid women has limited use this highly effective method birth control.
To examine characteristics of U.S. women that are associated with use long-acting reversible contraception and changes in these between 2002 2006-2008.We analyzed data from two nationally representative samples aged 15-44 the National Survey Family Growth, including 7,643 7,356 2006-2008. We conducted simple multinomial logistic regression analyses to identify demographic reproductive health contraception.Long-acting (intrauterine devices subdermal implants) among using increased 2.4% 5.6%...
Is it possible to extend the use of 3-year one-rod etonogestrel (ENG)-releasing subdermal contraceptive implant 5 years? The extended ENG-releasing showed 100% efficacy in years 4 and 5. initial regulated trials on conducted 1990 s were designed measure cumulative efficacy. ENG-implant has both well established safety for up 3 years. Pharmacokinetic data ENG show high levels at some previous clinical research confirms beyond current approved duration Today, many women, because labeled been...
BACKGROUND: Increased menstrual bleeding and pain are the primary side effects that lead to early removal of copper intrauterine device (IUD). Ibuprofen other non-steroidal anti-inflammatory drugs (NSAIDs) proven treatments for such IUD-induced problems, but their effect on IUD is unknown. METHODS: A total 2019 first-time users were recruited in Chile this double-blind, randomized, placebo-controlled trial. Half participants given ibuprofen instructions take 1200 mg daily during menses (for...
The IUD was once a popular form of birth control in the US. It is noted that sharp drop use resulted from combination interrelated factors and events. However since almost impossible to misuse far less likely fail than pill condom or injectable national increase comes at expense such methods would reduce number unintended pregnancies. This paper outlines comprise history future Factors as new research documenting safety clear public health need many advantages over other reversible...